William Blair Issues Pessimistic Estimate for USPH Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – William Blair decreased their Q3 2025 earnings per share estimates for shares of U.S. Physical Therapy in a research note issued to investors on Monday, August 11th. William Blair analyst J. Haase now expects that the company will earn $0.68 per share for the quarter, down from their prior estimate of $0.70. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s FY2025 earnings at $2.45 EPS and FY2027 earnings at $3.23 EPS.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.10. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%. The firm had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. During the same quarter last year, the firm posted $0.73 EPS. The business’s revenue was up 18.0% on a year-over-year basis.

A number of other analysts have also recently commented on USPH. Wall Street Zen raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday, May 8th. JMP Securities reiterated a “market outperform” rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Finally, Barrington Research boosted their price objective on U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an “outperform” rating in a research note on Friday, August 8th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $110.25.

U.S. Physical Therapy Stock Performance

NYSE:USPH opened at $85.92 on Thursday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.17 and a current ratio of 1.18. The stock has a market capitalization of $1.31 billion, a PE ratio of 37.52, a P/E/G ratio of 4.52 and a beta of 1.45. U.S. Physical Therapy has a fifty-two week low of $62.77 and a fifty-two week high of $101.19. The company has a fifty day moving average of $77.39 and a two-hundred day moving average of $77.06.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 22nd will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 22nd. U.S. Physical Therapy’s dividend payout ratio (DPR) is 78.60%.

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the business’s stock in a transaction on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the transaction, the director owned 2,594 shares of the company’s stock, valued at approximately $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Graham D. Reeve sold 1,792 shares of the company’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $86.57, for a total value of $155,133.44. Following the completion of the sale, the chief operating officer owned 22,246 shares of the company’s stock, valued at approximately $1,925,836.22. The trade was a 7.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of institutional investors have recently bought and sold shares of USPH. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of U.S. Physical Therapy by 952.4% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company’s stock worth $32,000 after purchasing an additional 400 shares during the period. Parallel Advisors LLC lifted its position in U.S. Physical Therapy by 90.6% in the second quarter. Parallel Advisors LLC now owns 448 shares of the company’s stock valued at $35,000 after buying an additional 213 shares during the last quarter. Cullen Frost Bankers Inc. lifted its position in U.S. Physical Therapy by 171.8% in the second quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock valued at $35,000 after buying an additional 280 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in U.S. Physical Therapy during the fourth quarter worth about $39,000. Finally, Assetmark Inc. increased its position in shares of U.S. Physical Therapy by 35.7% during the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock valued at $45,000 after acquiring an additional 150 shares during the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.